Literature DB >> 23085904

Dynamic contrast-enhanced optical imaging of in vivo organ function.

Cyrus B Amoozegar1, Tracy Wang, Matthew B Bouchard, Addason F H McCaslin, William S Blaner, Richard M Levenson, Elizabeth M C Hillman.   

Abstract

Conventional approaches to optical small animal molecular imaging suffer from poor resolution, limited sensitivity, and unreliable quantitation, often reducing their utility in practice. We previously demonstrated that the in vivo dynamics of an injected contrast agent could be exploited to provide high-contrast anatomical registration, owing to the temporal differences in each organ's response to the circulating fluorophore. This study extends this approach to explore whether dynamic contrast-enhanced optical imaging (DyCE) can allow noninvasive, in vivo assessment of organ function by quantifying the differing cellular uptake or wash-out dynamics of an agent in healthy and damaged organs. Specifically, we used DyCE to visualize and measure the organ-specific uptake dynamics of indocyanine green before and after induction of transient liver damage. DyCE imaging was performed longitudinally over nine days, and blood samples collected at each imaging session were analyzed for alanine aminotransferase (ALT), a liver enzyme assessed clinically as a measure of liver damage. We show that changes in DyCE-derived dynamics of liver and kidney dye uptake caused by liver damage correlate linearly with ALT concentrations, with an r2 value of 0.91. Our results demonstrate that DyCE can provide quantitative, in vivo, longitudinal measures of organ function with inexpensive and simple data acquisition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085904      PMCID: PMC3434471          DOI: 10.1117/1.JBO.17.9.096003

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  36 in total

1.  Perfusion CT findings in liver of patients with tumor during chemotherapy.

Authors:  Qing Zhang; Zhen-Guo Yuan; Dao-Qing Wang; Zhi-Hui Yan; Jun Tang; Zuo-Qin Liu
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  DCE-MRI model selection for investigating disruption of microvascular function in livers with metastatic disease.

Authors:  Anita Banerji; Josephine H Naish; Yvonne Watson; Gordon C Jayson; Giovanni A Buonaccorsi; Geoffrey J M Parker
Journal:  J Magn Reson Imaging       Date:  2011-10-10       Impact factor: 4.813

3.  Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window.

Authors:  Kevin Welsher; Sarah P Sherlock; Hongjie Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

Review 4.  Free radicals and tissue injury: fact and fiction.

Authors:  T F Slater
Journal:  Br J Cancer Suppl       Date:  1987-06

5.  Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers.

Authors:  Sílvia Nosàs-Garcia; Thomas Moehler; Klaus Wasser; Fabian Kiessling; Reiner Bartl; Ivan Zuna; Jens Hillengass; Hartmut Goldschmidt; Hans-Ulrich Kauczor; Stefan Delorme
Journal:  J Magn Reson Imaging       Date:  2005-07       Impact factor: 4.813

6.  Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study.

Authors:  M Gurfinkel; A B Thompson; W Ralston; T L Troy; A L Moore; T A Moore; J D Gust; D Tatman; J S Reynolds; B Muggenburg; K Nikula; R Pandey; R H Mayer; D J Hawrysz; E M Sevick-Muraca
Journal:  Photochem Photobiol       Date:  2000-07       Impact factor: 3.421

7.  Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations.

Authors:  Haruo Watanabe; Masayuki Kanematsu; Satoshi Goshima; Hiroshi Kondo; Minoru Onozuka; Noriyuki Moriyama; Kyongtae T Bae
Journal:  Radiology       Date:  2011-01-19       Impact factor: 11.105

8.  Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans.

Authors:  G Schuhmann-Giampieri; M Mahler; G Röll; R Maibauer; S Schmitz
Journal:  J Clin Pharmacol       Date:  1997-07       Impact factor: 3.126

9.  Indocyanine green. Its use as an early indicator of hepatic dysfunction following injury in man.

Authors:  M E Gottlieb; H H Stratton; J C Newell; D M Shah
Journal:  Arch Surg       Date:  1984-03

10.  In vivo quantification of optical contrast agent dynamics in rat tumors by use of diffuse optical spectroscopy with magnetic resonance imaging coregistration.

Authors:  David J Cuccia; Frederic Bevilacqua; Anthony J Durkin; Sean Merritt; Bruce J Tromberg; Gultekin Gulsen; Hon Yu; Jun Wang; Orhan Nalcioglu
Journal:  Appl Opt       Date:  2003-06-01       Impact factor: 1.980

View more
  5 in total

1.  Acceleration of dynamic fluorescence molecular tomography with principal component analysis.

Authors:  Guanglei Zhang; Wei He; Huangsheng Pu; Fei Liu; Maomao Chen; Jing Bai; Jianwen Luo
Journal:  Biomed Opt Express       Date:  2015-05-08       Impact factor: 3.732

2.  Paradigms in Fluorescence Molecular Imaging: Maximizing Measurement of Biological Changes in Disease, Therapeutic Efficacy, and Toxicology/Safety.

Authors:  Jeffrey D Peterson
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

3.  Dynamic contrast enhanced fluorescent molecular imaging of vascular disruption induced by combretastatin-A4P in tumor xenografts.

Authors:  Li Liu; Xing Su; Ralph P Mason
Journal:  J Biomed Nanotechnol       Date:  2014-08       Impact factor: 4.099

4.  Early Detection of Acute Drug-Induced Liver Injury in Mice by Noninvasive Near-Infrared Fluorescence Imaging.

Authors:  Kristine O Vasquez; Jeffrey D Peterson
Journal:  J Pharmacol Exp Ther       Date:  2017-01-23       Impact factor: 4.030

5.  Noncontact recognition of fluorescently labeled objects in deep tissue via a novel optical light beam arrangement.

Authors:  Andreas Hien; Marc Pretze; Frank Braun; Edgar Schäfer; Tim Kümmel; Mareike Roscher; Daniel Schock-Kusch; Jens Waldeck; Bernhard Müller; Carmen Wängler; Matthias Rädle; Björn Wängler
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.